Cargando…
Icariside II induces rapid phosphorylation of endothelial nitric oxide synthase via multiple signaling pathways
Icariside II, as a favonoid compound derived from epimedium, has been proved to involed in a variety of biological and pharmacological effects such as anti-inflammatory, anti-osteoporosis, anti-oxidation, anti-aging, and anti-cancer but its mechanism is unclear, especially in terms of its effect on...
Autores principales: | Song, Wenpeng, Yuan, Yiming, Tan, Xiaohui, Gu, Yangyang, Zeng, Jianyu, Song, Weidong, Xin, Zhongcheng, Fang, Dong, Guan, Ruili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615964/ https://www.ncbi.nlm.nih.gov/pubmed/36312762 http://dx.doi.org/10.7717/peerj.14192 |
Ejemplares similares
-
AB239. Icariside II enhances endothelial nitric oxide synthase expression by suppressing miR-155 in diabetic-like human cavernous endothelial cells
por: Guan, Ruili, et al.
Publicado: (2016) -
AB184. Icariside II induces NO production in human cavernous endothelial cells via the activation of eNOS by miR-155
por: Lei, Hongen, et al.
Publicado: (2015) -
Icariside II ameliorates endothelial dysfunction by regulating the MAPK pathway via miR-126/SPRED1 in diabetic human cavernous endothelial cells
por: Lei, Hongen, et al.
Publicado: (2018) -
AB238. Effect of Icariside II on miR-126 pathway on human cavernous endothelial cells exposed to a diabetic-like environment
por: Lei, Hongen, et al.
Publicado: (2016) -
AB176. Icariside II ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats
por: Tian, Wenjie, et al.
Publicado: (2015)